Janux Therapeutics, Inc. (JANX)

13.07 +0.89 (+7.31%) USD  |  NASDAQ  |  Feb 06, 16:00
13.02 -0.05 (-0.38%) After-Hours: 20:00
More

Janux Therapeutics SG&A Expense (TTM) : 39.13M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for JANX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Bristol Myers Squibb Co. 7.267B
Eli Lilly & Co. 11.09B
Ionis Pharmaceuticals, Inc. 351.68M
MannKind Corp. 195.42M
Madrigal Pharmaceuticals, Inc. 715.08M